Molecular pathogenesis of HIV-associated lymphomas

Area of Science:

• Oncology
• Virology
• Genetics

Background:

• Acquired immunodeficiency syndrome-related non-Hodgkin lymphoma (AIDS-NHL) pathogenesis involves complex genetic alterations.
• Understanding these genetic changes is crucial for targeted therapies.

Purpose of the Study:

• To investigate the association of genetic alterations including Epstein-Barr virus (EBV) infection, oncogene activation (c-myc, ras), and tumor suppressor gene (p53) inactivation in AIDS-NHL.
• To determine the distribution and preferential associations of these lesions among different histotypes.

Main Methods:

• Analysis of genetic alterations in AIDS-NHL patient samples.
• Histopathological examination and molecular analysis for EBV, oncogenes, and tumor suppressor genes.

Main Results:

• Multiple genetic lesions (up to four) were observed in individual tumors.
• p53 mutations/loss were exclusively associated with the SNCC lymphoma subtype.
• EBV infection was common in AIDS-Lymphocryptovirus-associated primary central nervous system lymphoma (AIDS-LC-IBP) but less frequent in systemic AIDS-NHL.
• Ras oncogene mutations were infrequent and mainly associated with Burkitt lymphoma (BL).

Conclusions:

• Genetic alterations, including p53 inactivation and c-myc activation, play a significant role in the pathogenesis of specific AIDS-NHL subtypes like SNCC.
• EBV is likely required for the pathogenesis of AIDS-LC-IBP.
• The genetic landscape of AIDS-NHL is heterogeneous, with distinct patterns observed across different histotypes.